Trotabresib, CAS 1706738-98-8

Product Description: CC-90010 (compound 1) is a reversible and orally active BET inhibitor. CC-90010 is applied in the study for advanced solid tumors[1][2].

Applications: Cancer-programmed cell death

Formula: C21H21NO4S

References: [1]CELGENE QUANTICEL RESEARCH, INC. PROCESS FOR THE PREPARATION OF BROMODOMAIN INHIBITOR. Patent. WO2020023438./[2]V. Moreno, et al. CC-90010, a reversible, oral bromodomain and extra-terminal (BET) inhibitor in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory (R/R) non-Hodgkin lymphoma: Updated results of a phase I study.

CAS Number: 1706738-98-8

Molecular Weight: 383.46

Compound Purity: 99.53

Research Area: Cancer

Solubility: DMSO : 50 mg/mL (ultrasonic)

Target: Epigenetic Reader Domain

• SKU: MEXHY-137573-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-137573-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK